20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
#2702Use of the pat nanopeptide in the treatment of autoimmune diseases
#2703Compounds for treating beta-amyloidoses
#2704Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis
#2705COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
#2706Oligopeptide tyrosinase inhibitors and uses thereof
#2707HLA-binding peptide, precursor thereof, and DNA fragment and recombinant vector coding for said HLA-binding peptide
#2708ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGNOSTIC AGENTS
#2709NOVEL COMPOSITIONS AND THEIR USE
#2710Elastin producing fibroblast formulations and methods of using the same
#2711High affinity VEGF-receptor antagonists
#2712Inhibitors of mammalian tight junction opening
#2713Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders
#2714Cell proliferation reducing cancer specific PCNA peptides
#2715METHODS OF MODULATING T CELL- DEPENDENT IMMUNE RESPONSES
#2716Somatostatin receptor antagonists and glucose control or hypoglycemia
#2717USE OF FURIN CONVERTASE INHIBITORS IN THE TREATMENT OF FIBROSIS AND SCARRING
#2718Compositions and methods for promoting wound healing and tissue regeneration
#2719Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
#2720METHODS FOR TREATING SEPTIC SHOCK
#2721Cosmetic uses of modified stressed yeast extracts and related compositions
#2722Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
#2723COMPOSITIONS, KITS AND METHODS FOR TREATING BENIGN PROSTATE HYPERPLASIA
#2724TARGETED ANTIMICROBIAL MOIETIES
#2725TARGETED ANTIMICROBIAL MOIETIES
#2726Targeted antimicrobial moieties
#2727COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS
#2728Interferon gamma receptor beta chain compositions and methods of inhibiting apoptosis
#2729Ophthalmic drug delivery system containing phospholipid and cholesterol
#2730Methods for treatment of pain
#2731Auristatin drug linker conjugates
#2732Compositions comprising E-selectin antagonists and uses therefor
#2733Histidine related compounds for identifying and blocking amyloid beta ion channels
#2734METHODS FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE (AD)
#2735Control of radiation injury
#2736Protein kinase C peptides for use in withdrawal
#2737Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
#2738Uses of Myostatin Antagonists
#2739Ex vivo uses of immunostimulatory combinations
#2740Treatment of immunocompromised conditions
#2741Decoy-containing pharmaceutical compositions and method of using the same
#2742Self-assembling complex for targeting chemical agents to cells
#2743Casein Derived Peptides And Uses Thereof
#2744Methods for reducing CD36 expression
#2745RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY
#2746Methods for reducing oxidative damage
#2747Ninjurin-1 modulation and uses thereof
#2748Pharmaceutical Compositions for treating wouds and related methods
#2749INHIBITING AGENT FOR INHIBITION OF ANGIOGENESIS, A METHOD FOR PREPARING THE AGENT, A METHOD FOR MODIFYING THE AGENT AND ITS USE FOR MANUFACTURING A MEDICAMENT FOR TREATING TUMOR
#2750Casein Derived Peptides And Uses Thereof in Therapy
#2751Methods and compositions for the treatment of proteinuric diseases
#2752Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis
#2753Low burst polymers and methods to produce polymer
#2754HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#2755Method of treatment or prophylaxis of inflammatory pain
#2756Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
#2757LIGAND OF REGULATING IMMUNE RESPONSE, AND USE THEREOF IN TREATING AN IMMUNE RESPONSE-RELATED DISEASE
#2758METHODS COMPRISING DESMOPRESSIN
#2759Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase
#2760Detection of mage-A expression
#2761Method for treating celiac disease
#2762SUPPRESSION AND TREATMENT OF NEUROPATHIC PAIN
#2763CD36 MODULATION AND USES THEREOF
#2764Use of a peptide and an analgesic pharmaceutical agent
#2765Enterostatin as Therapeutic Agent for Hypoglycemia
#2766Antimicrobial compounds and formulations
#2767Modifications of cupredoxin derived peptides and methods of use thereof
#2768Derivatised proline containing peptide compounds as protease inhibitors
#2769Method for increasing cardiac mass and performance
#2770Methods for Detecting and Inhibiting Angiogenesis
#2771METHOD FOR INDUCING CYTOTOXIC T-CELLS, CYTOTOXIC T-CELL INDUCERS, AND PHARMACEUTICAL COMPOSITIONS AND VACCINES EMPLOYING THEM
#2772Composition and method for preventing and treating immune-related disorder
#2773COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA
#2774Calcium-binding agents induce hair growth and/or nail growth
#2775USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#2776Compositions and methods for treating ocular diseases and conditions
#2777CLK-peptide and SLK-peptide
#2778Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)
#2779Peptoid oligomers, pharmaceutical compositions and methods of using the same
#2780IAP BIR DOMAIN BINDING COMPOUNDS
#2781Compositions and methods for treatment of cancer
#2782COMPOSITIONS AND METHODS FOR ENHANCING NEUROPROTECTION VIA ADMINISTRATION OF STEM CELLS AND BLOOD BRAIN BARRIER PERMEABILIZERS
#2783Neuroprotection using NAP-like and SAL-like peptide mimetics
#2784USE OF THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS AS A THERAPEUTIC AGENT
#2785Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
#2786Compositions for Diminishing the Appearance of Wrinkles
#2787Methods of using enterostatin as inhibitor of angiogenesis
#2788Azapeptides as CD36 binding compounds
#2789DRUG OR FOOD CONTAINING A PEPTIDE
#2790USE OF THE PEPTIDE ASN-ASP-ASP-CYS-GLU- LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU ALONE OR IN COMBINATION WITH THE PEPTIDE THR-THR-SER-GLN-VAL- ARG-PRO-ARG AS A THERAPEUTIC AGENT
#2791USE OF THE PEPTIDE COMBINATION THYMOSIN BETA 4 AND DELTA SLEEP INDUCING PEPTIDE AS A THERAPEUTIC AGENT
#2792Modulation of activity of proneurotrophins
#2793Cupredoxin derived transport agents and methods of use thereof
#2794COMBINATION OF SPLENOPENTIN AND THYMOPENTIN AND THE USE THEREOF IN MEDICINE
#2795USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#2796USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS
#2797USE OF GLUTEN EXORPHIN C : AS A THERAPEUTIC AGENT
#2798Methods For Delivering Thymosin Beta 4, Analogues, Isoforms and Other Derivatives
#2799USE OF THE PEPTIDES MAIPPKKNQDK (COW KAPPA CASEIN 106-116) AND/OR YGFQNA (SERORPHIN) AS THERAPEUTIC AGENTS
#2800USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#2801THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
#2802ASTRESSIN AND BETA- ENDORPHIN FOR USE AS THERAPEUTIC AGENTS
#2803Pharmaceutical formulation
#2804Non-proteolysable oligopeptides that inhibit glycoprotein GP41 of the aids virus
#2805THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ
#2806USE OF A RGD-PEPTIDE AND/OR PARATHYROID HORMONE (1-34) AS ANTI-HIV AGENT
#2807USE OF THE PEPTIDE THYMOSIN BETA 4 ALONE OR IN COMBINATION WITH CECROPIN A AS A THERAPEUTIC AGENT
#2808ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY
#2809METHOD FOR REDUCING INTRACRANIAL PRESSURE
#2810USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT
#2811β-arrestin effectors and compositions and methods of use thereof
#2812USE OF A DESLORELIN AND MASTOPARAN AS A THERAPEUTIC AGENT
#2813Peptides and their use
#2814Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation
#2815ANTIBACTERIAL AND ANTIFUNGAL PEPTIDES
#2816ANTIBACTERIAL AND ANTIFUNGAL PEPTIDES
#2817Antibacterial and antifungal peptides
#2818USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#2819USE OF GLUCAGON (1-29) ALONE OR IN COMBINATION WITH NEUROPEPTIDE W30 AS A THERAPEUTIC AGENT
#2820Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator
#2821COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS
#2822Peptides for inhibiting chemokine binding to chemokine receptors
#2823PEPTIDE NANOPARTICLES AND USES THEREFOR
#2824PROTEINS FOR USE IN DIAGNOSING AND TREATING INFECTION AND DISEASE
#2825CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION
#2826Boc and Fmoc solid phase peptide synthesis
#2827Pharmaceutical composition
#2828Proteinase K inhibitors, methods and compositions therefor
#2829Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccine
#2830Pharmaceutical and/or cosmetic composition containing peptides
#2831Treatment of inflammation and/or endotoxic shock
#2832System And Method For Reducing The Appearance Of Fine Lines And Wrinkles And Improving the Skin Tone
#2833METHOD OF DIAGNOSING AND TREATING ASTHMA
#2834Metal-binding compounds and uses therefor
#2835Polymeric biosurfactants
#2836Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof
#2837Peptidomimetic protease inhibitors
#2838Methods and compositions for treating conditions
#2839Method of reducing injury to mammalian cells
#2840Methods of modulating angiogenesis
#2841Casein-derived peptides having anxiolytic activity
#2842Stabilizing alkylglycoside compositions and methods thereof
#2843Tumor Activated Prodrugs
#2844Method and composition for inhibiting cardiovascular cell proliferation
#2845METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF INFLUENZA
#2846PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#2847Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide
#2848Ophthalmological composition
#2849CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE
#2850TREAMENT FOR CHEMICAL SUBSTANCE ADDICTION
#2851Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage
#2852Peptides, derivatives and analogs thereof, and methods of using same
#2853Peptides for the regulation of neurotransmitter sequestration and release
#2854Compositions and methods for treatment of eye disorders
#2855COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#2856Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
#2857Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
#2858Peptide-presenting surfaces for long-term culture of pluripotent cells
#2859SELECTIVE PEPTIDES THAT INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN
#2860Surfaces containing antibacterial polymers
#2861Hemiasterlin derivatives and uses thereof in the treatment of cancer
#2862Methods for treating pain
#2863ErbB-2 receptor targeting peptide
#2864Methods of administering a material into a patient for dermal enhancement
#2865Method for Inhibiting Angiogenesis
#2866Pharmaceutical Compositions Including Low Dosages of Desmopressin
#2867METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#2868ASSOCIATION OF COMPOUNDS INHIBITING MELANOGENESIS AND USE THEREOF IN COSMETICS AND DERMATOLOGY
#2869Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions
#2870Sincalide Formulations
#2871HCV protease inhibitors and uses thereof
#2872Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
#2873AMIDATED DOPAMINE NEURON STIMULATING PEPTIDES FOR CNS DOPAMINERGIC UPREGULATION
#2874METHODS FOR TREATING VIRAL DISORDERS
#2875Cosmetic compositions
#2876Skin repair compositions comprising circadian gene activators and a synergistic combination of 1 gene activators
#2877Peptides directed for diagnosis and treatment of amyloid-associated diseases
#2878Sustained release glp-1 receptor modulators
#2879MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
#2880METHOD FOR TREATING SKIN
#2881METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#2882Amphiphilic peptides and hydrogel matrices thereof for bone repair
#2883HYPOTENSIVE PEPTIDES FROM SOY PROTEINS AND METHOD OF PREPARATION
#2884Pharmaceutical compositions and methods for peptide treatment
#2885Methods for promoting wound healing and/or reducing scar formation
#2886Protein kinase C therapy for the treatment of acute lung injury
#2887Composition for acceleration of type I collagen production
#2888ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY
#2889Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
#2890Pharmaceutical formulations
#2891TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) WITH ANTI-ANGIOGENIC COMPOUNDS
#2892Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
#2893USE OF TIGHT JUNCTION AGONISTS TO FACILITATE PULMONARY DELIVERY OF THERAPEUTIC AGENTS
#2894Control of radiation injury
#2895Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
#2896Methods for improving the structure and function of arterioles
#2897Gene Regulation
#2898CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
#2899Elastin digest compositions and methods utilizing same
#2900Method of reducing injury to mammalian cells
#2901Control of radiation injury
#2902COLLYRIUM FOR DRY EYE
#2903Methods of increasing cerebral blood flow
#2904Therapeutic uses of biocompatible biogel compositions
#2905Utilization of peptides as active ingredients for slimming
#2906Methods for reducing CD36 expression
#2907Highly fluorinated β-amino acids and methods of making and using same
#2908Engineered integrin binding peptides
#2909Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disorders
#2910Compositions and Methods for Topical Application and Transdermal Delivery of an Oligopeptide
#2911High affinity VEGF-receptor antagonists
#2912ψεRACK peptide composition and method for protection against tissue damage due to ischemia
#2913COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS
#2914Methods and uses for protein breakdown products
#2915Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
#2916PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6 TO PREVENT AND ELIMINATE FIBROSIS AND OTHER PATHOLOGICAL DEPOSITS IN TISSUES
#2917Injectable Combination Therapy for Eye Disorders
#2918Method and compositions for treating skin
#2919UV-induced dermatitis inhibitor and atopic dermatitis inhibitor
#2920Pharmaceutically Active Antiviral Peptides
#2921VIVIT POLYPEPTIDES, THERAPEUTIC AGENT COMPRISING THE SAME, AND METHOD OF SCREENING FOR ANTI-CANCER AGENT
#2922Compositions and methods for promoting wound healing and tissue regeneration
#2923Peptide mixtures with immunomodulatory activity
#2924GUS3 NEUROPEPTIDES FOR REGULATING HYPOTHALAMIC FUNCTION
#2925Methods of protecting against apoptosis using lipopeptides
#2926Methods and compositions related to targeting tumors and wounds
#2927METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#2928Method of treating metastatic stage prostate cancer
#2929Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1
#2930Methods for attenuating release of inflammatory mediators and peptides useful therein
#2931Neuritogenic peptides
#2932Casein derived peptides and uses thereof
#2933Peptides that selectively home to heart vasculature and related conjugates and methods
#2934Methods and Compositions for Reducing Ischemia-Derived Microvascular Damage
#2935Methods and Compositions for the Inhibition of Thrombus Formation
#2936METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE
#2937Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
#2938INHIBITORS OF AMYLOID PRECURSOR PROTEIN PROCESSING
#2939METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF CROHN'S DISEASE
#2940Angiogenic peptides and uses thereof
#2941METHODS OF TREATING BLOOD CELL DEPLETION
#2942PEPTIDES FOR DIAGNOSTIC AND THERAPEUTIC METHODS FOR CELIAC SPRUE
#2943Use of anti-amyloid agents for treating and typing pathogen infections
#2944Use of effectors of glutaminyl and glutamate cyclases
#2945Modulation of lipid rafts
#2946Compositions and methods for enhancing apoptosis
#2947Method of stimulating the motility of the gastrointestinal system using ipamorelin
#2948Methods of treatment by administering anti-connexin proteins and mimetics
#2949Agents for reducing injury to mammalian cells
#2950LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGE
#2951Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
#2952Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
#2953Specific therapy using integrin ligands for treating cancer
#2954Compositions and methods for treating neural anoxia and spreading depression
#2955Suppression of inflammation associated with transplantation using an epsilon PKC inhibitor
#2956TLR9 agonist and CD40 agonist immunostimulatory combinations
#2957Methods of screening for compounds that inhibit binding between amyloid-β(Aβ) and FC-γ receptor IIB (FcγRIIb)
#2958Immune-modulating peptide
#2959LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
#2960Method of treating chemotherapy-induced thrombocytopenia
#2961Compositions and methods for promoting hemostasis and other physiological activities
#2962Elastin protective polyphenolics and methods of using the same
#2963Combination therapy
#2964Compositions and methods of use of targeting peptides against placenta and adipose tissues
#2965Virus derived antimicrobial peptides
#2966Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma
#2967Oligopeptide tyrosinase inhibitors and uses thereof
#2968AGENT FOR CORRECTING STRESS-INDUCING NEURO-MEDIATOR, NEURO-ENDOCRINE AND METABOLIC DISTURBANCES AND METHOD FOR PREVENTING AND TREATING CONCOMITANT PATHOLOGICAL CONDITIONS
#2969CALCIUM BINDING PEPTIDES
#2970Therapeutic agent for irritable bowel syndrome
#2971Tumor-targeted drug delivery systems and uses thereof
#2972Cosmetic and pharmaceutical compounds for inducing the synthesis of SIRT proteins in skin and methods of use thereof
#2973MAST CELL-DERIVED RENIN
#2974Prodrugs activated by plasmin and their use in cancer chemotherapy
#2975Anticancer compounds and methods
#2976Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions
#2977USE OF TIGHT JUNCTION ANTAGONISTS TO TREAT INFLAMMATORY BOWEL DISEASE
#2978INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#2979Peptides which bind to G protein-coupled receptors
#2980POLYVALENT INHIBITORS OF PATHOGENS
#2981Insulin and IGF-1 Receptor Agonists and Antagonists
#2982Compositions and methods for treating diseases
#2983ANTI-MICROBIAL COMPOSITIONS AND DEVICES AND METHODS OF USING THE SAME
#2984Neuroprotective dietary supplement
#2985Use of mitochondria-targeted electron scavengers as anti-inflammatory agents
#2986INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#2987Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
#2988Compositions and methods for the diagnosis and treatment of tumor
#2989COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha
#2990Immunogenic peptides and methods of use
#2991Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
#2992HLA-BINDING PEPTIDE, PRECURSOR THEREOF, AND DNA FRAGMENT AND RECOMBINANT VECTOR CODING FOR SAID HLA-BINDING PEPTIDE
#2993Thymosin beta 4 compositions and methods
#2994METHODS AND COMPOSITIONS FOR TREATING CARDIAC DYSFUNCTIONS
#2995HLA binding peptides and their uses
#2996Pharmaceutical compositions including low dosages of desmopressin
#2997TOPICAL COMPOSITIONS FOR DELAYING EJACULATION AND METHODS OF USING THE SAME
#2998VIP fragments and methods of use
#2999Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers
#3000Method of controlling tight blood glucose by somatostatin receptor antagonists